NCT03439982View on ClinicalTrials.gov

Fecal Transplant for Hepatic Encephalopathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 12, 2016

Primary Completion Date

August 7, 2019

Study Completion Date

March 18, 2021

Conditions
Hepatic Encephalopathy
Interventions
BIOLOGICAL

FMT

FMT processed from routinely screened donors

Trial Locations (1)

Unknown

University of Alberta Hospital, Edmonton

All Listed Sponsors
collaborator

Rebiotix Inc.

INDUSTRY

lead

University of Alberta

OTHER

NCT03439982 - Fecal Transplant for Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter